Full Video Transcript
The U.S. Food and Drug Administration approved Xarelto in July 2011. It's mainly prescribed to people with deep vein thrombosis and individuals with heart rhythm disorders to prevent blood clot formation. People who were taking this drug started experiencing internal bleeding immediately thereafter. Anyone who's taken Xarelto and experienced serious side effects including death, internal bleeding, venous thrombosis events, pulmonary embolism, pink or brown urine, unusual bleeding from the gums to name a few, may pursue a claim against the manufacture of Xarelto. Xarelto was manufactured by Janssen & Bayer. If you suffered internal bleeding side effects as a result of Xarelto, you could be entitled to compensation.